Click to search for your profile
Click to search for condition or expert
Click to open main menu
Acute Myelomonocytic Leukemia
Symptoms, Doctors, Treatments, Advances & More
Save
Bookmark
Share
Share
Overview
Find a Doctor
Latest Advances
Clinical Trials
Condition 101
About Acute Myelomonocytic Leukemia
What are the alternative names for Acute Myelomonocytic Leukemia?
AML-M4
Acute myeloblastic leukemia type 4
AML M4
AMMoL
Top Global Doctors
For Acute Myelomonocytic Leukemia
Bookmark
Click to see options
MS
Elite
Mikkael A. Sekeres
Hematology
Oncology
Internal Medicine
Miami, FL
Bookmark
Click to see options
MP
Elite
Mrinal M. Patnaik
Hematology
Oncology
Internal Medicine
Rochester, MN
Bookmark
Click to see options
EW
Elite
Eunice S. Wang
Hematology
Oncology
Internal Medicine
Buffalo, NY
Bookmark
Click to see options
HK
Elite
Hagop M. Kantarjian
Oncology
Hematology
Internal Medicine
Houston, TX
Bookmark
Click to see options
RK
Elite
Rami S. Komrokji
Oncology
Hematology
Internal Medicine
Tampa, FL
Bookmark
Click to see options
CD
Elite
Courtney D. Dinardo
Hematology
Oncology
Internal Medicine
Houston, TX
Latest Advances
On Acute Myelomonocytic Leukemia
Journal:
International journal of molecular sciences
Published —
June 02, 2021
NKL Homeobox Gene VENTX Is Part of a Regulatory Network in Human Conventional Dendritic Cells.
Condition:
Children with High-Risk Leukemia
Journal:
Transplantation and cellular therapy
Treatment Used:
Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide Using a Reduced-Intensity Conditioning Regimen and Peripheral Blood as the Stem Cell Source
Number of Patients:
42
Published —
May 09, 2021
This study evaluated the long-term results of haploidentical donor hematopoietic stem cell transplantation (half matched stem cell transplant from a family member) with post-transplantation cyclophosphamide using a reduced-intensity conditioning regimen and peripheral blood (the flowing, circulating blood of the body) as the stem cell source for children with high-risk leukemia (group of blood cancers that usually begin in the bone marrow and result in high numbers of abnormal blood cells).
Clinical Trials
For Acute Myelomonocytic Leukemia
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 1
Intervention Type:
Drug
Participants:
72
Start Date:
December 21, 2021
A Phase 1 Study of MLN7243 (TAK-243) for Either Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome/Chronic Myelomonocytic Leukemia Refractory to Hypomethylating Agents
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 1/Phase 2
Intervention Type:
Biological, Drug
Participants:
36
Start Date:
September 2021
An Open-label Phase IB/II Study of DSP107 for Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) and T-cell Lymphoproliferative Disease
